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Abstract
Background: Different biologic approaches to treat disc regeneration, including growth factors (GFs) application,
are currently under investigation. Human annulus fibrosus (hAF) repair or regeneration is one of the key elements
for maintenance and restoration of nucleus pulposus function. However, so far there is no effective treatment for
this purpose. The aim of the present study was to investigate the response of hAF cells to different combinations of
GFs, and develop a protocol for efficient culture expansion.
Methods: hAF cells were harvested from degenerated disc tissues during surgical intervertebral disc removal, and
hAF cells were expanded in a monolayer. The experiments were categorized based on different protocols with
transforming growth factor (TGF-β1) and fibroblast growth factor (FGF-2) culture for 14 days: group 1 had no GFs
(control group); group 2 received TGF-β1; group 3 received FGF-2; group 4 received both GFs; and group 5
(two-step) received both GFs for the first 10 days and TGF-β1 only for the next 4 days. Cell proliferation, collagen,
and noncollagen extracellular matrix (ECM) production and genes expression were compared among these groups.
Results: At days 3, 7 and 10 of cultivation, groups 4 and 5 had significantly more cell numbers and faster cell
proliferation rates than groups 1, 2, and 3. At 14 days of cultivation, significantly more cell numbers were observed
in groups 3 and 4 than in group 5. The group 4 had the most cell numbers and the fastest proliferation rate at 14
days of cultivation. After normalization for cell numbers, group 5 (two-step) produced the most collagen and
noncollagen ECM at 10 and 14 days of cultivation among the five groups. In group 5, ECM gene expression was
significantly upregulated. High expression of matrix metalloproteinase-1 was upregulated with FGF-2 on the
different days as compared to the other groups. Annulus fibrosus cell phenotypes were only marginally retained
under the different protocols based on quantitative polymerase chain reaction results.
Conclusion: Taken together, the two-step protocol was the most efficient among these different protocols with
the most abundant ECM production after normalization for cell numbers for culture expansion of hAF cells. The
protocol may be useful in further cell therapy and tissue engineering approaches for disc regeneration.
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Background
Back pain resulting from degenerative disc disease
(DDD) is one of the most common causes of disability
worldwide [1]. The process of intervertebral disc degen-
eration is an aberrant, cell-mediated response to pro-
gressive structural failures which is evident on routine
clinical imaging studies [2]. Moreover, the pathogenesis
of DDD is still a complicated process [2] with tissue
weakening resulting from genetic inheritance, aging, nu-
tritional compromise, and mechanical loading [1].
Previous studies have indicated a strong association
between human annulus fibrosus (hAF) tear (circumferen-
tial tear, radial fissure, or peripheral rim) and disc degener-
ation [3]. As an integral part of the disc, the hAF plays an
essential role in the pathogenesis of disc degeneration. It
has been reported that the hAF sealing augmentation
method and regeneration could facilitate nucleus pulposus
(NP) tissue engineering [4]. Disc degeneration is known to
accompany hAF biochemical changes, and hAF might still
play an important role in disc degeneration [3].
Major components of the extracellular matrix (ECM) in
hAF are water, collagens (60–70 % dry weight; mostly type
I and less so type III [1, 5]), and proteoglycan (15–20 %
dry weight) [6]. The hAF cells regulate ECM homeostasis
with a variety of stimuli, including cytokines and growth
factors (GFs), and maintain their steady state in the nor-
mal disc [7, 8]. Disc degeneration may result from an im-
balance between anabolic and catabolic processes and loss
of the steady metabolism [5]. Evidence has indicated that
matrix metalloproteinases (for example, MMP-1 and
MMP-3) and aggrecanases (ADAMTS-4) were upregu-
lated [6, 9], and has revealed a catabolic state and possible
pathogenic roles in ECM degradation that are character-
ized in DDD, including hAF [6].
GFs in vitro acted as anabolic regulators of hAF cell
metabolism; the GFs included insulin-like growth factor
(IGF)-1 [10–12], transforming growth factor (TGF)-β1
[10, 13], fibroblast growth factor (FGF)-2 [12], and
platelet-derived growth factor (PDGF) [11, 12]. These
studies indicated that different GFs had different
anabolic effects on hAF cells in either a monolayer
[11, 12] or three-dimensional cultures in agarose or
alginate [10, 13].
FGF-2 [14] was described as a mitogen for fibroblastic
cells and as being involved in tissue regeneration. Re-
garding morphogen, TGF-β1 was superior to IGF-1,
PDGF, and FGF-2 in upregulating aggrecan synthesis
[15, 16]. Increased expression of FGF-2 and TGF-β1 and
its receptors were found in human degenerated or herni-
ated discs [17, 18]. It was assumed that disc degener-
ation stimulated or triggered the release of FGF-2 and
TGF-β1 by the disc itself. Consequently, these two GFs
may play important roles in biologic repair or rescue of
the degeneration. With tissue engineering for hAF cells,
one of the key elements is to amplify large numbers of
cells and produce more ECM [4] simultaneously. Studies
[10–13] have evaluated the effects of continuous isolated
single or combined GF treatment for tissue expansion of
hAF cells in vitro. However, no study has compared the
results regarding culture expansion of hAF cells under
different combination of GFs.
The objective of this study was to evaluate cell prolif-
eration and ECM production of hAF cells harvested
from degenerated disc tissues under different combina-
tions of GFs, consisting of FGF-2 and TGF-β1 in vitro.
We hypothesize that hAF cells harvested from degener-
ated disc tissues respond differently to combinations of
GFs.
Methods
The study was approved by the ethics committee of
Taipei Veterans General Hospital. Human disc tissues
were obtained from six patients (four female and two
male donors; mean age 57 years, range 52–61 years) di-
agnosed as having lumbar spondylolisthesis, and who
underwent transforaminal interbody fusion (TLIF) sur-
gery. The patients signed informed consent to partici-
pate before surgery.
To exclude contamination by the inner NP tissues, the
most inner AF layers were discarded. hAF tissue from
degenerated disc tissues were finely minced prior to
enzymatic digestion. hAF tissues were digested for 30
min at 37 °C under gentle agitation in phosphate-
buffered saline (PBS) containing 0.1 % collagenase,
and then digested at room temperature for another
30 to 40 min with gentle sterile agitation under a
laminar flow hood.
After the hAF tissues had been digested for 1 h, the
tiny fragmented tissues were passed through filters, cen-
trifuged, and cultured in dishes that were supplemented
with Dulbecco’s modified Eagle medium (DMEM;
Sigma-Aldrich, St. Louis, MO, USA) with 10 % fetal bo-
vine serum (FBS; HyClone, Logan, UT, USA), 100 UI
penicillin, 1000 UI streptomycin, and 2 mm L-glutamine
(Invitrogen, Carlsbad, CA, USA). The dishes were incu-
bated at 37 °C in a humidified atmosphere of 5 % CO2,
95 % air under normoxia (20 % O2). A change of
medium was carried out twice a week.
Once hAF cells (passage 0) reached 70–80 % conflu-
ence, cells were detached with 0.25 % trypsin–ethylene-
diaminetetraacetic acid (Gibco BRL), washed twice with
PBS, centrifuged at 1000 rpm for 4 min, and cultured in
the P-100 flask (passage 1). After reaching 70–80 % con-
fluence, the cells were harvested and expanded in the
flask using the same methods (passage 2). Once passage
2 cells had reached confluence, the hAF cells were de-
tached by trypsin, washed with PBS, and cryopreserved
in liquid nitrogen in FBS with 10 % dimethyl sulfoxide
Chou et al. Stem Cell Research & Therapy  (2016) 7:89 Page 2 of 10
(DMSO). Cells from passage 3 were used for the subse-
quent experiments to avoid dedifferentiation when cul-
tured in vitro after a long passage (greater than passage
6) [19], which could interfere with the experimental
results.
TGF-β1 and FGF-2 (Sigma-Aldrich) were prepared fol-
lowing the manufacturer’s instructions, and were added
to the LG-DMEM medium to achieve a working con-
centration of 5 ng/mL TGF-β1 and 10 ng/mL FGF-2.
The five groups were categorized using different proto-
cols consisting of TGF-β1 and FGF-2 treatment for 14
days (Fig. 1): group 1 was a control group with no GFs;
groups 2, 3, and 4 were one-step protocols with TGF-β1
or FGF-2 or combined GF treatment, respectively; group
5 was a two-step protocol, with both GFs for the first
10 days and then TGF-β1 treatment only for the next 4
days. FBS was not used in any of the experimental
groups, including the control group. To generate star-
vation, cells were cultured in DMEM medium with
Corning™ ITS (insulin, transferrin, selenium) solution
for 24 h.
Aprroximately 3 × 104 cells were placed in P60 dishes
for the five groups. Cultured media were changed twice
a week. Serial passage was performed when cells reached
confluence, usually at days 7 and 10. Cell numbers were
summed together during passage. Cell numbers were
determined on days 3, 7, 10, and 14 by trypan blue ex-
clusion in a Neubauer counting chamber. Three inde-
pendent experiments were performed at each time
point.
A total of 1.5 × 103 cells were placed in each well of a
96-well plate. For cell proliferation, we used the Cell
Proliferation ELISA BrdU assay (Roche Molecular Bio-
chemicals, Mannheim, Germany), according to the man-
ufacturer’s protocol, on days 3, 7, 10, and 14. Briefly,
cells were labeled with 10 uM 5-bromo-2’-deoxyuridine
(BrdU) for 1 h. The cells were then fixed, and DNA was
denatured for 30 min. After 1 h of incubation with a
peroxidase-coupled anti-BrdU antibody, cells were
washed three times with PBS. Thereafter, peroxidase
substrate (tetramethylbenzidine) was added for 30 min
and chemiluminescence measurements were performed
on a luminometer (Tecan’s Infinite M1000 microplate
reader). Three independent experiments were performed
at each time point.
Collagen and noncollagen ECM proteins were quanti-
fied by colorimetric analyses, as described previously
[20, 21], on days 7, 10 and 14. Selective binding of Sirius
Red F3BA to collagen and Fast Green FCF (Sigma
Chemical) to noncollagen protein was used when both
were dissolved in aqueous saturated picric acid. In all,
3 × 104 cells in each well of a six-well plate were incu-
bated with 1 mL saturated picric acid solution that con-
tained 0.1 % Sirius Red F3BA and 0.1 % Fast Green FCF.
The plates were incubated at room temperature for 30
min in a rotary shaker. The fluids were then carefully
withdrawn, and the plates were washed two to three
times with distilled water until the fluid was colorless.
After washing with water, 1 mL 1:1 (equal volume) 0.1 %
NaOH and absolute methanol was added to each well to
Fig. 1 Experimental flowchart and the five groups using one-step and two-step protocols consisting of TGF-β1 and FGF-2 treatment for 14 days.
Group 1: control group with no growth factor (GF). Group 2: one-step protocol with TGF-β1 5 ng/mL. Group 3: one-step protocol with FGF-2
10 ng/mL. Group 4: one-step protocol with treatment with both GFs. Group 5: two-step protocol with treatment with both GFs for the first 10 days
and then TGF-β1 only for the next 4 days. BrdU 5-bromo-2’-deoxyuridine, ECM extracellular matrix, FGF fibroblast growth factor, qPCR quantitative
polymerase chain reaction, TGF transforming growth factor
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elute the color. The elute color was immediately analyzed
with a spectrophotometer at 540 and 605 nm (U3300 Pro;
Amersham Biosciences, Freiburg, Germany), respectively.
Three independent experiments were performed at each
time point.
Cells (3 × 104 seeded in P60 dishes for the five groups)
were subcultured when confluence was reached. Targeted
genes were analyzed at 3, 7, 10, and 14 days by quantita-
tive real-time polymerase chain reaction (PCR). Total
RNA was extracted using an RNeasy Mini Kit (QIAGEN,
Stanford, Valencia, CA, USA). RNA samples were used for
reverse transcription and subsequent PCR amplification.
Quantitative real-time PCR was performed with a Light-
Cycler 480 Real-Time System (Roche Applied Sciences,
Mannheim, Germany). Intron spanning primers for tar-
geted genes were designed by the Universal ProbeLibrary
Assay Design Center and detected with corresponding
probes (Roche) (Table 1). The glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) housekeeping gene was used for
endogenous internal control. All targeted genes were nor-
malized using GAPDH and analyzed using the 2–△△Ct
method expressed as fold-change. Three independent ex-
periments were performed at each time point.
For each disc sample, three replications were performed
in each experiment for cell number, cell proliferation, pic-
ric acid stain, and qPCR analysis. Statistical significance
among groups was analyzed using the repeated-measure
analysis of variance (ANOVA) test with post hoc test
(Bonferroni test) (SPSS 15.0; SPSS, Chicago, IL, USA).
A p value less than 0.05 indicated statistical significance.
Results
The doubling time of hAF cells was approximately
67.8 ± 11 h in primary culture. hAF cells had astrocyte-
like morphology with one or three protrusions in a
primary monolayer. Cells treated without GFs had a
morphology similar to those cultured in a monolayer
(Fig. 2a, f ). Cells in group 2 (TGF-β1) had a more flat-
tened shape; these cells tended to aggregate to form
linear or circular multiple cell complexes when cell
contact occurred (Fig. 2b, g). Cells in group 3 (FGF-2)
had more homogenous smaller cells, with short cell
processes (Fig. 2c, h). Groups 4 (combined GFs; Fig. 2d, i)
and 5 (two-step; Fig. 2e, j) had a mixed cellular
morphology.
At 7 and 10 days of cultivation, the cell numbers were
significantly higher in groups 4 and 5 than in groups 1,
2, and 3. Up to day 10, both GFs were used in groups 4
and 5. These GFs might have a synergistic effect on cell
growth. At 14 days of cultivation, the cell numbers in
groups 3 and 4 were significantly 1.95 and 3.58 times
higher, respectively, than those in group 5 (Fig. 3). At 3,
7 and 10 days of cultivation, groups 4 and 5 had signifi-
cantly faster cell proliferation rates than groups 1, 2, and
3 after normalization by the control group. The group 4
had the fastest proliferation rate at 14 days of cultiva-
tion. The cell numbers results were compatible with the
proliferation results. (Fig. 4).
To examine the macromolecules of the ECM, we
stained cell cultures with Sirius Red for collagen and
Fast Green for noncollagen protein (Fig. 5a, b, c).
Table 1 Primers used in the real-time polymerase chain reaction analysis
Target gene Forward primer Reverse primer GenBank accession no. Roche probe no.
Housekeeping gene
GAPDH agccacatcgctcagacac gcccaatacgaccaaatcc NM_002046 #60
Anabolic genes
COL IA1 gggattccctggacctaaag ggaacacctcgctctcc NM_000088 #67
COL IIIA1 ctggaccccagggtcttc catctgatccagggtttcca NM_000090 #20
Aggrecan cctccccttcacgtgtaaaa gctccgcttctgtagtctgc NM_01135 #76
Catabolic genes
MMP-1 gctaacctttgatgctataactacga tttgtgcgcatgtagaatctg NM_001145938.1 #7
MMP-3 caaaacatatttctttgtagaggacaa ttcagctatttgcttgggaaa NM_002422 #36
ADAMTS-4 ccaggcactgggctactact gaacagggggtcccatcta NM_005099 #67
AF putative genes
COL1A1 gggattccctggacctaaag ggaacacctcgctctcc NM_000088 #67
COL2A1 tggtgctaatggcgagaag cccagtctctccacgttcac NM_033150.2 #4
COL5A1 gggattccctggacctaaag ggaacacctcgctctcc NM_000093.3 #42
COL12A1 cctggatgaggaggtgtttg cagcactggcgacttagaaa NM_004370.5 #89
SFRP-2 gctagcagcgaccacctc tttttgcaggcttcacatacc NM_003013.2 #83
ADAMTS a disintegrin and metallopeptidase with thrombospondin motif, COL collagen, GAPDH glyceraldehyde-3-phosphate dehydrogenase, MMP matrix metallopeptidase,
SFRP secreted frizzled-related protein
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Looking at gross appearance at 14 days of culture, stains
were strongly present in groups 4 and 5, while groups 1
and 3 were weakly stained, and group 2 showed inter-
mediate stain. With a spectrophotometer, the highest
collagen and noncollagen protein production was ob-
served in group 5, and the lowest in groups 1 and 3 at
14 days. The most abundant amount of collagen and
noncollagen production was significantly observed in
group 5 (two-step). At day 10, significantly greater colla-
gen and noncollagen production was also noted in
groups 4 and 5, but there was no statistical significance
between them.
We adopted the formula from Gascon-Barre et al. [21]
to quantify estimated collagen (μg) and noncollagen
(mg) ECM proteins. After normalization for cell number,
group 5 (two-step) statistically produced the most collagen
and noncollagen ECM at 10 and 14 days of cultivation
among the five groups, except in comparison to group 2
(which was statistically insignificant; Fig. 6a, b).
Statistically significant upregulation of collagen I, colla-
gen III, and aggrecan genes was seen in groups 2 and 5 as
compared to the other groups at 14 days (Fig. 7). There
were trends for upregulation of collagen I, collagen III, and
aggrecan gene expression observed in groups 2 and 5 at
day 10. Relatively low gene expression of collagen I, colla-
gen III, and aggrecan were observed in group 3 at days 10
and 14. Expression of MMP-1 was upregulated in the
FGF-2 group on different days as compared to the other
groups. In addition, the catabolic gene expression of
MMP-3 and ADAMT-4 were similar between groups at
different days of culture.
We aimed to confirm the AF phenotype maintenance
after passage by measuring expression of putative AF
markers. Based on van den Akker et al. [22] and Minogue
et al. [23], the characteristics of AF-specific gene ex-
pression (Table 1) were relative high expression of
COL1A1, COL5A1, COL12A1, and SFRP2, and rela-
tively low expression of the COL2/COL1 ratio as com-
pared to NP cells. Moreover, SFRP2 was exclusively
expressed in primary AF cells [23]. Unfortunately, we
did not collect the matched NP tissue for individual
disc samples. We compared the selected gene expres-
sion at 10 and 14 days of cultivation to those at day 0
(n = 2). AF cell phenotypes were only marginally
retained under the different protocols based on our
qPCR results (Fig. 8).
Fig. 2 Morphology of hAF cells harvested from degenerated disc tissues after GF treatment in the five groups. Control group at (a) 7 days and (f)
14 days. TGF-β1 group at (b) 7 days and (g) 14 days. FGF-2 group at (c) 7 days and (h) 14 days. Treatment group with both GFs at (d) 7 days
and (i) 14 days. Two-step group at (e) 7 days and (j) 14 days. Scale bar = 100 μm
Fig. 3 Cell numbers in the five groups. Approximately 3 × 104 hAF
cells were placed in each P60 dish and cultured. Cells were
harvested and counted at days 3, 7, 10, and 14. The results were
averaged and expressed as the mean ± standard deviation. Each
point indicates the mean of three experiments in the same group
(n = 6). *Cell numbers were significantly greater in groups 4 and 5
than in groups 1, 2, and 3 at 7 and 10 days of cultivation. **Cell
numbers in groups 3 and 4 were significantly greater than in group
5 at 14 days of cultivation. FGF fibroblast growth factor, GF growth
factor, TGF transforming growth factor
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Fig. 4 Relative expression of the BrdU results in the five groups normalized by the control group. hAF cells (1500) were placed in each well of a
96-well plate for the five groups. Cell proliferation was evaluated by luminometer. Each point indicates the mean of three experiments in the
same group (n = 6). The results of the relative expression ratio in the different groups were normalized by the control group at different days of
cultivation. The relative expression ratio was expressed as the mean ± standard deviation. At days 3, 7 and 10 of cultivation, groups 4 and 5
had significantly faster cell proliferation rates than groups 1, 2, and 3. The group 4 had the fastest cell proliferation rate at 14 days of cultivation. BrdU
5-bromo-2’-deoxyuridine, FGF fibroblast growth factor, GF growth factor, TGF transforming growth factor
Fig. 5 Collagen and noncollagen ECM protein production in the five groups. hAF cells (3 × 104 cells) were placed in each well of a six-well plate
for the five groups. The culture plates were stained with Sirius Red and Fast Green for collagen and noncollagen proteins at days 7, 10, and 14,
eluted, and absorbance was evaluated with a spectrophotometer at 540 and 605 nm, respectively. Each bar indicates the mean of three experiments
in the same group (n = 6). a Gross staining in the five groups at day 14. b Microscopic pictures were taken in the five groups at 14 days. Scale
bars = 100 μm. c Absorbance is shown (mean ± standard deviation). The value at each bar is the mean of three experiments in the same group.
*Significantly more collagenous and noncollagenous protein production in groups 4 and 5 at day 10 (but no significance between them). **The
most collagenous and noncollagenous protein production was significantly observed in the two-step protocol among the groups at 14 days.
FGF fibroblast growth factor, GF growth factor, TGF transforming growth factor
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Discussion
The goal of the two-step protocol was to synergistically
boost cell numbers at the first step by mitogen (FGF-2)
and morphogen (TGF-β1), and to obtain more ECM by
morphogen (TGF-β1) in the second step during cultiva-
tion. Li et al. [7] found that FGF-2 was anti-anabolic and
decreased proteoglycan synthesis in bovine disc cells.
We also found that FGF-2 had a positive effect on cell
numbers (mitogen) but had negative effects on ECM for-
mation in our study. Consequently, we administrated
only TGF-β1 in the second step of cultivation to trigger
ECM production in conjugation with little anabolic ef-
fect on cell proliferation after boosting cells numbers in
the first step.
Growth factors (GFs) are fundamental components of
the biological homeostasis of ECM in hAF cells [8]. In
hAF tissues of degenerated or herniated discs, FGF-2
could be observed by immunohistochemical stain [17,
18]. As a consequence, FGF-2 might participate in the
process of disc degeneration or repair in the degenerated
stage. We assumed that either the stage of degeneration
or the degenerative process could explain the different
anabolic or catabolic roles of FGF-2 in the degenerated
disc. From our results, FGF-2 could enhance cell prolif-
eration, inhibit ECM production, and downregulate
ECM genes relative to collagen I and collagen III in the
hAF cells. We may assume that there would be different
results if the hAF cells were taken from normal healthy
Fig. 6 Estimated collagen and noncollagen ECM protein production normalized by cell number (×104) in the five groups at 10 and 14 days of
cultivation. The formula for ECM protein calculation was adopted from Gascon-Barre et al. [21]. After normalization for cell number, group 5
(two-step) statistically produced the most collagen and noncollagen ECM, except when compared to group 2 (TGF-β1) (which was statistically
insignificant). a Estimated collagen amount (μg) normalized for cell number (×104) at 10 and 14 days of cultivation. b Estimated noncollagen
amount (mg) normalized for cell number (×104) at 10 and 14 days of cultivation. FGF fibroblast growth factor, GF growth factor, TGF transforming
growth factor
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discs postmortem. FGF-2 may create a cascade in hAF
tissues, where they act and participate in cellular remod-
eling from the normal stage to disc degeneration and
further herniation.
Previous studies [12, 16, 24] revealed that FGF-2 acted
as a mitogen [8] in human disc cells [12] or other spe-
cies [16, 24]. Pratsinis et al. [12] reported that DNA syn-
thesis in hAF cells obtained from herniated discs was
enhanced by PDGF, IGF, and FGF-2 via MEK/ERK and
PI-3K/Akt pathways. Thompson et al. [16] reported that
FGF-2 enhanced cell proliferation and matrix synthesis
in the canine disc. Pratsinis et al. [24] also reported that
FGF-2 stimulated cell proliferation of bovine discs via
the ERK and Akt signaling pathways. Li et al. [7] showed
that FGF-2 had its anti-anabolic effect in a bovine disc
via stimulation of MMP-13 production, and inhibition of
ECM production via MAPK and NF-kB pathways. We
found that FGF-2 could enhance cell proliferation, in-
hibit ECM production, downregulate ECM genes, and
upregulate the MMP-1 gene in our study. The real role
of FGF-2 in hAF harvest from degenerated disc tissue
still needs to be analyzed to clarify its possible roles in
disc degeneration.
Peng et al. [17] and Tolonen et al [18] reported that
TGF-β1 was found in human NP (hNP) and posterior
AF tissues in the painful degenerated disc via immuno-
chemical staining. No studies have reported the anti-
anabolic effect of TGF-β1 on hAF cells. Its appearance
in degenerated discs may explain its essential role in
repairing or rescuing degeneration. Gruber et al. [10] re-
ported that TGF-β1 (5 ng/mL) enhanced proteoglycan
production and cell proliferation for hAF cells in three-
dimensional culture. Gruber et al. [13] also reported that
TGF-β1 (1 ng/mL) had few mitogenic effects on hAF
cells after cultivation for 4 days. We found TGF-β1
(5 ng/mL) had a synergistically mitogenic effect on FGF-2,
but much higher morphogenic effects on hAF cells. If we
normalized the amount of ECM production for total cell
number, we might find each cell in the TGF-β1 group pro-
duced more ECM; our goal was also to produce more
ECM in the second step, following the boosting of cell
production in the first step.
Interleukin (IL)-1 has been identified in the herniated
human disc [9, 25]. hNP cells responded to IL-1β via the
p38 MAPK signaling pathway [25]. Le Maitre et al. [9]
reported that MMP-3, MMP-13, and ADAMTS-4 genes
were upregulated following 10 ng/mL IL-1β treatment in
degenerated hAF cells. In our study, IL-1β was upregu-
lated not only in the control group, but also in the other
groups on different cultivation days. There was a trend
in which GF treatment downregulated IL-1β gene ex-
pression but did not downregulate other downstream
catabolic genes, especially at day 10. Other cytokines be-
sides IL-1β (tumor necrosis factor (TNF)-α, IL-6, IL-8,
prostaglandin E2 (PGE2), and nitric oxide (NO) [26, 27])
may also be involved in the complicated pathogenesis of
Fig. 7 Relative quantitative gene expression in the five groups. Cells (3 × 104) were seeded in P60 dishes for the five groups. Relative quantitative
gene expression of (a) collagen I, (b) collagen III, (c) aggrecan, (d) MMP-1, (e) MMP-3, and (f) ADAMTS-4 were analyzed at days 3, 7, 10, and 14 by
semi-qPCR. Data represent mean ± standard deviation (n = 6). Each bar indicates the mean of three experiments in the same group. Statistically
high expression of collagen I, collagen III, and aggrecan genes was observed in the TGF-β1 and two-step groups. Statistically lower expression of
ECM genes were observed in the FGF-2 group at 7, 10, and 14 days. *Statistically significant upregulated gene expression. ADAMTS a disintegrin
and metalloproteinase with thrombospondin motif, FGF fibroblast growth factor, GF growth factor, MMP matrix metalloproteinase,
TGF transforming growth factor
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disc degeneration, including upregulation of MMP genes.
Monolayer culture, which is different from the naive en-
vironment, may accelerate disc degeneration and may ex-
plain the gradual upregulation of the IL-1β gene in the
control group (data not shown). The results were similar
as discovered by Kluba et al [28].
For a clinical application, there are limitations in this
study that have to be considered. First, our results were
from a monolayer cell culture model, which does not
reflect the real three-dimensional disc environment in
vivo. Second, there are potentially harmful side effects
following locally exogenous GF therapy for AF biologic
repair, as reported by Price et al. [29]. Moreover, we did
not harvest postmortem healthy disc tissue for our
study, which may have less dedifferentiated effects after
subsequent cell passage than our protocol. Moreover, we
did not quantify each of the corresponding proteins. We
might use other GFs in further experiments, which could
be more efficient than our two-step protocols. In
addition, AF cell phenotypes were only marginally
retained under the different protocols. This could be due
to the GF effects. In fact, withdrawal of GFs from the
cell culture media after 14 days of treatment might shift
AF cells back to their original phenotype.
Conclusion
In summary, the findings in this study have extended the
knowledge regarding the effects of FGF-2 and TFG-β1
on hAF cells harvested from degenerated disc tissues.
The two-step protocol was more efficient compared to
the one-step protocols regarding isolated or combined
treatment for hAF cell culture expansion, with moderate
cell numbers obtained but most abundant ECM produc-
tion. The two-step protocol with FGF-2 and TGF-β1
may be a useful formula for hAF culture expansion in
future applications for cell therapy of the intervertebral
disc.
Abbreviations
ADMATS-4: a disintegrin and metalloproteinase with thrombospondin motif-4;
BrdU: 5-bromo-2’-deoxyuridine; DDD: degenerative disc disease;
DMEM: Dulbecco’s modified Eagle medium; ECM: extracellular matrix;
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